Drug and clinical candidate information for mt-nd1 (ChEMBL ID: CHEMBL1777):

Molecule: ATOVAQUONE
ChEMBL ID: CHEMBL1450
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1992
Drug and clinical candidate information for mt-nd1 (ChEMBL ID: CHEMBL3869):

Molecule: CTS-1027
ChEMBL ID: CHEMBL440498
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: REBIMASTAT
ChEMBL ID: CHEMBL76222
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Small molecule
Drug and clinical candidate information for mt-nd1 (ChEMBL ID: CHEMBL2363065):

Molecule: METFORMIN HYDROCHLORIDE
ChEMBL ID: CHEMBL1703
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1995

Molecule: ME-344
ChEMBL ID: CHEMBL5314386
Mechanism of Action: INHIBITOR
Max Phase: 1.0
Molecule Type: Small molecule

Molecule: NV-128
ChEMBL ID: CHEMBL3545135
Mechanism of Action: INHIBITOR
Max Phase: 1.0
Molecule Type: Small molecule
